Clinical Cancer Research AACR Conference on Cancer Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asano, T.
Right arrow Articles by Miwa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asano, T.
Right arrow Articles by Miwa, M.
Clinical Cancer Research Vol. 8, 1157-1167, April 2002
© 2002 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Expressions of Cyclooxygenase-2 and Prostaglandin E-Receptors in Carcinoma of the Gallbladder

Crucial Role of Arachidonate Metabolism in Tumor Growth and Progression1

Toru Asano, Junichi Shoda2, Tetsuya Ueda, Toru Kawamoto, Takeshi Todoroki, Manabu Shimonishi, Tadashi Tanabe, Yukihiko Sugimoto, Atsushi Ichikawa, Michihiro Mutoh, Naomi Tanaka and Masanao Miwa

Departments of Gastroenterology [T. A., J. S., M. M., N. T.] and Gastrointestinal Surgery [T. K., T. T.], Institute of Clinical Medicine, University of Tsukuba, Tsukuba-shi, Ibaraki 305-8575; Department of Pharmaceutical Research, Mitsubishi Kagaku Bio-Clinical Laboratories, Inc., Itabashi-ku, Tokyo 174-8555 [T. U.]; Department of Pharmacology, National Cardiovascular Center Research Institute, Fujishirodai, Suita, Osaka 565-8565 [M. S., T. T.]; Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, University of Kyoto, Yoshida, Sakyo-ku, Kyoto 606-8501 [Y. S., A. I.]; Cancer Prevention Division, National Cancer Research Institute, Chuo-ku, Tokyo 104-0045 [M. M.]; and Department of Biochemistry and Molecular Oncology, Institute of Basic Medical Science, University of Tsukuba, Tsukuba-shi, Ibaraki 305-8575 Japan [M. M.]

An association of gallbladder carcinoma with cholelithiasis suggests that chronic inflammation may modulate tumorigenesis and/or progression of the carcinoma. An enhanced expression of cyclooxygenase-2 (COX-2) is observed frequently in advanced carcinomas of gastrointestinal tracts, which in turn suggests that potentiated arachidonate metabolism may play a crucial role in tumor biology. In the present study, the expression levels of COX-2 and prostaglandin E receptor subtypes were determined in 16 cases of gallbladder carcinomas of different depths of invasion (pT1 3, pT2 2, pT3 4, and pT4 7) to determine the role of arachidonate metabolism in tumor growth and progression. The mRNA levels of COX-2 were increased significantly in pT3 and pT4 carcinomas compared with the levels in pT1 and pT2 carcinomas. Immunohistochemistry and in situ hybridization revealed the existence of COX-2 mRNA and protein in both the cancerous epithelia and adjacent stroma of pT1-pT4 carcinomas. Only in pT3 and pT4 carcinomas was intense expression of COX-2 observed in the adjacent stroma. The tissue concentration of PGE2 was significantly increased in pT3 and pT4 carcinomas. The mRNAs of PGE receptor subtypes EP2, EP3, and EP4 were amplified in pT1-pT4 gallbladder carcinomas, in which their mRNAs and EP4 protein were expressed mostly in the cancerous epithelia. Treatment with a specific EP4 agonist, as well as PGE2 but not EP2 and EP3 agonists, up-regulated the expression of c-fos, an induced growth response gene, and increased colony formation. In advanced gallbladder carcinoma, enhanced expression of COX-2 is observed in the adjacent stroma rather than in the cancerous epithelia, and the stroma is a potent source of PG synthesis. In epithelial-stromal interactions, the increased PGE2 synthesis in the adjacent stroma and its biological effect via EP4 on the carcinoma cells may contribute to tumor growth and progression of gallbladder carcinoma.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
K. Kiguchi, L. Ruffino, T. Kawamoto, E. Franco, S.-i. Kurakata, K. Fujiwara, M. Hanai, M. Rumi, and J. DiGiovanni
Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice
Mol. Cancer Ther., June 1, 2007; 6(6): 1709 - 1717.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Han, J. D. Ritzenthaler, B. Wingerd, H. N. Rivera, and J. Roman
Extracellular Matrix Fibronectin Increases Prostaglandin E2 Receptor Subtype EP4 in Lung Carcinoma Cells through Multiple Signaling Pathways: THE ROLE OF AP-2
J. Biol. Chem., March 16, 2007; 282(11): 7961 - 7972.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Yang, Y. Huang, R. Porta, K. Yanagisawa, A. Gonzalez, E. Segi, D. H. Johnson, S. Narumiya, and D. P. Carbone
Host and Direct Antitumor Effects and Profound Reduction in Tumor Metastasis with Selective EP4 Receptor Antagonism
Cancer Res., October 1, 2006; 66(19): 9665 - 9672.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. C. Sakoda, Y.-T. Gao, B. E. Chen, J. Chen, P. S. Rosenberg, A. Rashid, J. Deng, M.-C. Shen, B.-S. Wang, T.-Q. Han, et al.
Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China
Carcinogenesis, June 1, 2006; 27(6): 1251 - 1256.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Shoji, M. Takahashi, N. Takasuka, N. Niho, T. Kitamura, H. Sato, T. Maruyama, Y. Sugimoto, S. Narumiya, T. Sugimura, et al.
Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis
Carcinogenesis, December 1, 2005; 26(12): 2116 - 2122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Han, J. D. Ritzenthaler, B. Wingerd, and J. Roman
Activation of Peroxisome Proliferator-activated Receptor {beta}/{delta} (PPAR{beta}/{delta}) Increases the Expression of Prostaglandin E2 Receptor Subtype EP4: THE ROLES OF PHOSPHATIDYLINOSITOL 3-KINASE AND CCAAT/ENHANCER-BINDING PROTEIN {beta}
J. Biol. Chem., September 30, 2005; 280(39): 33240 - 33249.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Liu, L. C. Sakoda, Y.-T. Gao, A. Rashid, M.-C. Shen, B.-S. Wang, J. Deng, T.-Q. Han, B.-H. Zhang, J. F. Fraumeni Jr., et al.
Aspirin Use and Risk of Biliary Tract Cancer: A Population-Based Study in Shanghai, China
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1315 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Kubo, H. K. Takahashi, M. Takei, H. Iwagaki, T. Yoshino, N. Tanaka, S. Mori, and M. Nishibori
E-Prostanoid (EP)2/EP4 Receptor-Dependent Maturation of Human Monocyte-Derived Dendritic Cells and Induction of Helper T2 Polarization
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1213 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. L. Konger, G. A. Scott, Y. Landt, J. H. Ladenson, and A. P. Pentland
Loss of the EP2 Prostaglandin E2 Receptor in Immortalized Human Keratinocytes Results in Increased Invasiveness and Decreased Paxillin Expression
Am. J. Pathol., December 1, 2002; 161(6): 2065 - 2078.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.